Translational Research

 
Stock Quotes for Translational Research top ^
  • Industry: Computer Systems
  • Sector: Technology
  • Stock Type: Distressed
Sign-up for datx investment picks

 
News Articles for Translational Research top ^
2014/1/7
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1079738&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle Health Sciences Translational Research Center 3.0 Helps Advance Personalized Medicine investment picks
Sigma-Aldrich Corporation, in Collaboration with The American Association for the Advancement of Science (AAAS), Produces First-Ever "State of Translational Research Survey Report" ST.
Sign-up for Survey Conducted within the Academic Research Community Ignites Debate Around Data Reproducibility and Quality Standards in Translational Research investment picks
2014/2/11
NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the global commercial launch of the nCounter Elements ™ General Purpose Reagents (GPRs), a solution that enables clinical laboratories to independently develop multiplexed genomic assays and then rapidly translate those assays into clinical diagnostics as Laboratory Developed Tests (LDTs). The announcement, made at the 21 st International Molecular Medicine Tri-Conference (TRI-CON) taking place in San Francisco, February 9 – 14, marks the conclusion of a successful early access program that involved 22 participants from five countries in North America, Europe, and Asia.
Sign-up for NanoString Technologies Launches Commercial Reagents to Enable Laboratories to Rapidly Develop Tests From Translational Research Discoveries investment picks
2014/3/19
Partnership Seeks To Establish Clinical and Health Economic Benefits of Trovagene's Urine-Based Cell-Free Molecular Diagnostics for Potential Adoption in Cancer Management Strategies SAN DIEGO and BALTIMORE , March 19, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ:  TROV) and Catholic Health Initiatives Center for Translational Research (CTR) today announced they have entered into a strategic partnership to conduct clinical validation studies, clinical utility studies, health economic studies, and other activities to determine the effectiveness of Trovagene's urine-based cell-free DNA cancer monitoring diagnostics in clinical practice.
Sign-up for Trovagene and Catholic Health Initiatives Center for Translational Research Partner to Clinically Evaluate Non-Invasive Genomic Diagnostics to Improve Cancer Care investment picks
2014/2/27
LONDON, Feb.
Sign-up for RR Donnelley to Acquire Translation Technology Solutions Provider MultiCorpora investment picks
2014/1/27
Hospital organizations and physician practices can speed ICD-10 code conversion of electronic health record (EHR) systems with the latest release of the 3M Code Translation Tool (CTT). The enhanced ICD-10 code translation technology from 3M Health Information Systems can now be used to convert ICD-9-based custom problem lists into ICD-10 coded problem lists for import back into the EHR system.
Sign-up for 3M ICD-10 Code Translation Software Converts EHR Custom Problem Lists investment picks
2014/1/8
Data Translation today announced a new data acquisition module that can measure any type of sensor.
Sign-up for New USB High Accuracy, Multi-Sensor Module from Data Translation investment picks
2014/2/10
Vantage Health Inc. (OTCQB:VNTH) and its parent company Nanobeak Inc. today announced that they have formed a strategic partnership with Scripps Translational Science Institute (STSI) for the advancement of mobile health technology.
Sign-up for Vantage Health and Scripps Translational Science Institute form Strategic Partnership for Mobile Health Technology investment picks
2013/10/22
NEW YORK and REDWOOD CITY, California and HILDEN, Germany , October 22, 2013 /PRNewswire/ -- Mount Sinai collaboration with QIAGEN Center of Excellence in Biological Interpretation demonstrates translational value of high-quality analysis of gene variants in rare diseases Accuracy and ease of use for clinical and labora to ry geneticists and other medical professionals are cited in selection of genomic analysis solutions from QIAGEN Medical school also will use Ingenuity Variant Analysis   to   train next generation of medical professionals in genome interpretation QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that the Mount Sinai Genetic Testing Laboratory and the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai in New York City have adopted the Ingenuity ® Variant Analysis™ solution for research and
Sign-up for QIAGEN's Ingenuity® Variant Analysis™ Selected for Translational Genomics by Icahn School of Medicine at Mount Sinai investment picks
Leading scientists join together to discuss breakthrough research that addresses serious medical needs Young Investigator Awards presented to four promising researchers BASEL, Switzerland and NEW YORK , Oct.
Sign-up for Roche inaugurates Translational and Clinical Research Center at the Alexandria Center for Life Science in New York City investment picks
2013/10/17
Integrated Device Technology, Inc. ( IDT ® ) (NASDAQ:IDTI), the Analog and Digital Company™ delivering essential mixed-signal semiconductor solutions, today announced the third generation of its Universal Frequency Translator ( UFT ) family of timing devices for high-performance optical networks, wireless base stations, and 100 Gigabit Ethernet (GbE) interface applications.
Sign-up for IDT Announces Third-Generation High-Performance, Programmable Universal Frequency Translator for 100 Gbps Interfaces investment picks
2014/4/7
SAN DIEGO , April 7, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced the addition of Ian B.
Sign-up for Sorrento appoints Ian Walters as Senior Vice President of Translational Medicine and Corporate Development investment picks
2014/4/11
Oncolytics Biotech Inc. Collaborators Present Translational Brain Cancer Clinical Data and Immunomodulatory Preclinical Research at UK Oncolytic Virus Conference Canada NewsWire CALGARY , April 11, 2014 /CNW/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that Dr.
Sign-up for Oncolytics Biotech Inc. Collaborators Present Translational Brain Cancer Clinical Data and Immunomodulatory Preclinical Research at UK Oncolytic Virus Conference investment picks
2013/11/19
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1070232&ProfileId=051205&sourceType=1 SYDNEY, AUSTRALIA --
Sign-up for Prima BioMed's CEO to Present at 11th Annual Commercial Translation of Regenerative Medicine Meeting investment picks
Integrated Device Technology, Inc. ( IDT ® ) (NASDAQ: IDTI), the Analog and Digital Company™ delivering essential mixed-signal semiconductor solutions, today announced that its third-generation universal frequency translator (UFT) devices were included in EDN’s prestigious Hot 100 products list in the Analog product category.
Sign-up for IDT Third-Generation High-Performance Programmable Universal Frequency Translator Makes EDN Hot 100 List investment picks
2014/2/20
Widest voltage range logic translation devices reduce board space by more than 50 percent DALLAS , Feb.
Sign-up for TI introduces first fully integrated logic gate device with up/down translation investment picks
For the visually impaired, using a mobile device hasn’t always been easy.
Sign-up for Sprint Launches Kyocera Kona – Industry First Feature Phone with Verbal Translation of Internet Browsing investment picks
Leading Hotel Owner and Operator Gains 300 Percent Return on Investment While Boosting Guest Satisfaction and Achieving Smarter Business Insight NEW YORK , Nov.
Sign-up for IBM Big Data and Analytics Translates into Big Hotel Room Bookings for Denihan Hospitality Group investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1075074&ProfileId=051205&sourceType=1 PRINCETON, NJ and REHOVOT, ISRAEL --
Sign-up for Rosetta Collaborative Study Profiling microRNAs Published in Clinical & Translational Oncology investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Translational Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Transition Management  |  Next: Transmontaigne Partners